Last Price:
Date of Initial Coverage
04-Feb-21
Initial Entry Price
$0.040
Returns from Initial Entry
-80%
For FGL to find product market fit and earn significant revenues through key commercial partnerships, particularly Metcash.
Although FGL signed the Metcash deal in March 2021, it was not able to generate revenues from this deal. Without any significant cash flows from its product, the company has needed to raise capital at very low valuations. We are holding on to our FGL position to see if the company can find product market fit OR vend in a new project. We may sell our FGL position to free up capital for other investments.
✅ Initial Investment: @4c
🔲 Top Slice
🔲 Free Carry
🔲 Take Profit
🔲 Price increases 300% from initial entry
🔲 Price increases 500% from initial entry
🔲 Price increases 1000% from initial entry
✅ 12 Month Capital Gain Discount
🔲 Hold remaining Position for next 2+ years
| Date | Share Price $ | Title |
|---|---|---|
| 10-Mar-2021 | $ 0.056 | Tiny Retail Analytics Stock FGL Signs Deal with $3.4BN Wholesale Giant Metcash |
| 04-Feb-2021 | $ 0.057 | FGL - The Micro Cap ASX Tech Stock on the Cusp of Commercialisation |
Discover Small Cap
Biotech Stocks
Join thousands of other Investors following our stock commentary for Free
